Market Cap 3.50B
Revenue (ttm) 426.45M
Net Income (ttm) 197.67M
EPS (ttm) N/A
PE Ratio 25.05
Forward PE 23.06
Profit Margin 46.35%
Debt to Equity Ratio 0.18
Volume 2,977,100
Avg Vol 3,338,418
Day's Range N/A - N/A
Shares Out 238.63M
Stochastic %K 12%
Beta 0.47
Analysts Strong Sell
Price Target $32.33

Company Profile

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute e...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 478 5552
Fax: 201 478 5553
Address:
465 State Route 17, Ramsey, United States
ncost1
ncost1 Oct. 5 at 3:52 AM
$ADMA going to be a good year for us. Who cares about the manipulation. We know good times ahead. This is an easy double from here in about a year hopefully less.
0 · Reply
BeefStewart
BeefStewart Oct. 4 at 3:53 PM
$ADMA When looking at this, I am reminded of a time when I passionately loved a beautiful Vietnamese woman for 3 of the best years of my life. Every hug. Every kiss. Every sloppy thrust into the dark, damp depths of her Củ Chi tunnels. To be clear, many casualties during the Vietnam War can be attributed to the success of the tunnels of Củ Chi, & I never wish to make light of that. Despite that somber thought echoing in my mind throughout the 3 wonderful years that I shared with my Saigon sweetheart, I was undeterred by it from carpet bombing her Iron Triangle with my tongue, resulting in flooding monsoons that quenched even the greatest of droughts! At this point, some of you may be asking how this relates to ADMA, & if so, I question how serious of an investor you are. Regardless, I will humor you. Many of us have shared 3 magical years with ADMA, & at times suffered similar fates to the brave Tunnel Rats of Địa đạo Củ Chi, yet we persist because we know this is but 1 battle!
1 · Reply
FatLoads
FatLoads Oct. 4 at 1:28 AM
$ADMA feels like could drop to $11/12 at this point, pretty bummed
1 · Reply
Comingle
Comingle Oct. 4 at 12:16 AM
$ADMA we need some news here anything
0 · Reply
apatbeck79
apatbeck79 Oct. 3 at 9:33 PM
$ADMA patience
0 · Reply
buylocellhi
buylocellhi Oct. 3 at 7:24 PM
$ADMA I would not be surprised if one day next week we are up $1.25 per sh.
0 · Reply
Comingle
Comingle Oct. 3 at 6:47 PM
$ADMA lol Rigetti at 12b market cap with 2million revenue. what a world we live in.
2 · Reply
buylocellhi
buylocellhi Oct. 3 at 2:20 PM
$ADMA woo hoo!!! We are up a nickel!!! 😂
0 · Reply
buylocellhi
buylocellhi Oct. 3 at 2:01 PM
$ADMA got an alert on ASTC earlier in the week,, 😭,, this is a move ADMA needs to make! Lol
0 · Reply
buylocellhi
buylocellhi Oct. 3 at 1:46 PM
$ADMA the price was $24 going into 2nd qtr earnings, this is fkn nuts
0 · Reply
Latest News on ADMA
ADMA Biologics: A Better Quarter Than Headline Numbers

Aug 8, 2025, 3:58 PM EDT - 2 months ago

ADMA Biologics: A Better Quarter Than Headline Numbers


ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 9:14 PM EDT - 2 months ago

ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript


ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss

May 9, 2025, 3:54 AM EDT - 5 months ago

ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss


ADMA Biologics, Inc. (ADMA) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:05 PM EDT - 5 months ago

ADMA Biologics, Inc. (ADMA) Q1 2025 Earnings Call Transcript


ADMA Biologics Statement on Tariffs

Apr 7, 2025, 7:00 AM EDT - 6 months ago

ADMA Biologics Statement on Tariffs


ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 6:24 PM EST - 7 months ago

ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript


ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add

Feb 6, 2025, 1:46 PM EST - 8 months ago

ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add


ncost1
ncost1 Oct. 5 at 3:52 AM
$ADMA going to be a good year for us. Who cares about the manipulation. We know good times ahead. This is an easy double from here in about a year hopefully less.
0 · Reply
BeefStewart
BeefStewart Oct. 4 at 3:53 PM
$ADMA When looking at this, I am reminded of a time when I passionately loved a beautiful Vietnamese woman for 3 of the best years of my life. Every hug. Every kiss. Every sloppy thrust into the dark, damp depths of her Củ Chi tunnels. To be clear, many casualties during the Vietnam War can be attributed to the success of the tunnels of Củ Chi, & I never wish to make light of that. Despite that somber thought echoing in my mind throughout the 3 wonderful years that I shared with my Saigon sweetheart, I was undeterred by it from carpet bombing her Iron Triangle with my tongue, resulting in flooding monsoons that quenched even the greatest of droughts! At this point, some of you may be asking how this relates to ADMA, & if so, I question how serious of an investor you are. Regardless, I will humor you. Many of us have shared 3 magical years with ADMA, & at times suffered similar fates to the brave Tunnel Rats of Địa đạo Củ Chi, yet we persist because we know this is but 1 battle!
1 · Reply
FatLoads
FatLoads Oct. 4 at 1:28 AM
$ADMA feels like could drop to $11/12 at this point, pretty bummed
1 · Reply
Comingle
Comingle Oct. 4 at 12:16 AM
$ADMA we need some news here anything
0 · Reply
apatbeck79
apatbeck79 Oct. 3 at 9:33 PM
$ADMA patience
0 · Reply
buylocellhi
buylocellhi Oct. 3 at 7:24 PM
$ADMA I would not be surprised if one day next week we are up $1.25 per sh.
0 · Reply
Comingle
Comingle Oct. 3 at 6:47 PM
$ADMA lol Rigetti at 12b market cap with 2million revenue. what a world we live in.
2 · Reply
buylocellhi
buylocellhi Oct. 3 at 2:20 PM
$ADMA woo hoo!!! We are up a nickel!!! 😂
0 · Reply
buylocellhi
buylocellhi Oct. 3 at 2:01 PM
$ADMA got an alert on ASTC earlier in the week,, 😭,, this is a move ADMA needs to make! Lol
0 · Reply
buylocellhi
buylocellhi Oct. 3 at 1:46 PM
$ADMA the price was $24 going into 2nd qtr earnings, this is fkn nuts
0 · Reply
buylocellhi
buylocellhi Oct. 3 at 1:39 PM
$ADMA 🤪😂
0 · Reply
ConsistencySpike
ConsistencySpike Oct. 3 at 1:21 PM
0 · Reply
Sowa5000
Sowa5000 Oct. 3 at 11:21 AM
$ADMA $ADMA breakdown: Reduced Debt, 500 million dollar buyback, growth accelerating in the second half, 20 percent process improvement, new manufacturing facility in US ( should be good on tariff pressure)..Net income always a good word to hear! Time for the Rocket 🚀
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 10:33 AM
$ADMA: Unusual Options Activity Alerted CALL flow observed 500x contracts at Strike price of $20 Exp on 01/16/2026 with Premium of $30K and showing BULLISH Sentiment
0 · Reply
DeadManJoaquin
DeadManJoaquin Oct. 3 at 3:05 AM
$ADMA I had this from 2 -> 20ish... Time to get back in i think, the price action is inexplicable.
0 · Reply
Patastic
Patastic Oct. 3 at 1:42 AM
$ADMA Had to buy some more here. Only 300 shares. But I’m all in.
0 · Reply
GoldmanSlaps
GoldmanSlaps Oct. 2 at 8:52 PM
$ADMA call vol bullish
0 · Reply
oldhockeyplayerwithteeth
oldhockeyplayerwithteeth Oct. 2 at 8:25 PM
One of ADMA’s most significant milestones came in April 2025 when the U.S. Food and Drug Administration (FDA) approved its immunoglobulin yield‑enhancement process. This proprietary innovation allows the company to increase antibody yield by approximately 20% per plasma volume unit for both ASCENIV and BIVIGAM. This breakthrough has far-reaching implications. Not only will it enhance production capacity without requiring proportional increases in plasma collection, but it will also improve gross margins and overall profitability. Being the first U.S. manufacturer to secure such an approval, ADMA gains a clear competitive advantage that strengthens its moat in the plasma-derived products industry.$ADMA
2 · Reply
BeefStewart
BeefStewart Oct. 2 at 7:22 PM
$ADMA Honestly, this right here. Anyone who has been here since 2021/2022 has potentially made a killing here. Yes, it sucks right now as it's lagging the market, I suppose, but it's still around 7× to nearly 14× for those who bought in around late 2021 - early 2022. Ultimately, management continues to execute well, despite the stock performing poorly since late last year or so. Wishing everyone here great luck. If the price gets really stupid, I might slip a finger in 😏😉 I mean uhhm dip a toe in! 😳🥹🥰🙈🥰 For the time being, I'm very enthusiastic about $MXCT and hoping we see greater optimism in biotech overall! $XBI
0 · Reply
BrookeSummer
BrookeSummer Oct. 2 at 7:08 PM
$ADMA Can this thing just crash already to fill the damn gap or whatever technical line it needs to hit so we can start heading back up. Rip off the bandaid already.
1 · Reply
Comingle
Comingle Oct. 2 at 7:06 PM
$ADMA this market is so fucking retarded
0 · Reply
jerzbondon
jerzbondon Oct. 2 at 6:01 PM
$ADMA To feel better for the next 1 month just look at 3 year or 5 year chart of ADMA. 😊
0 · Reply